HomeClinical TopicsFDA approves new drug for severe asthma

FDA approves new drug for severe asthma

On Nov. 4, the U.S. Food and Drug Administration (FDA) approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients age 12 years and older. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content